Efficiently normalizing leukopoiesis by gadofullerene nanoparticles to ameliorate radiation-triggered myelosuppression.

Abstract

Myelosuppression is a predominant side-effect of radiotherapy, which manifests as the lower activity of blood cell precursors in bone marrow. Though progress in anti-myelosuppression has been made by the application of growth factors e.g., the granulocyte colony-stimulating factor (G-CSF), the side-effects (e.g., bone-pain, liver injury, and lung toxicity) limit their applications in clinic. Herein, we developed a strategy of efficiently normalizing leukopoiesis using gadofullerene nanoparticles (GFNPs) against myelosuppression triggered by radiation. Specifically, GFNPs with high radical-scavenging abilities elevated the generation of leukocytes and alleviated the bone marrow's pathological state under myelosuppression. Notably, GFNPs potentiated the differentiation, development, and maturation of leukocytes (neutrophils, lymphocytes) in radiation bearing mice even better than what G-CSF did. In addition, GFNPs had little toxicity towards the main organs including the heart, liver, spleen, lung, and kidney. This work provides an in-depth understanding of how advanced nanomaterials mitigate myelosuppression by regulating leukopoiesis.

• Authors: Wang Jia, Xue Li, Tian Zhang, Chunru Wang, Mingming Zhen
• Journal: Journal of materials chemistry. B (J Mater Chem B) Vol. 11 Issue 31 Pg. 7401-7409 (08 09 2023) ISSN: 2050-7518 [Electronic] England
• PMID: 37431674 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)

Chemical References

• gadofullerene
• Granulocyte Colony-Stimulating Factor
• Fullerenes

Topics

• Mice
• Animals
• Bone Marrow (pathology)
• Leukopoiesis
• Granulocyte Colony-Stimulating Factor (pharmacology)
• Fullerenes (pharmacology)